NovoCure Ltd — Investor Relations & Filings

NovoCure Ltd. is a global oncology company focused on developing and commercializing its proprietary cancer therapy platform, Tumor Treating Fields (TTFields). This non-invasive therapy utilizes electric fields tuned to specific frequencies to disrupt the division of solid tumor cancer cells, inhibiting tumor growth and causing cell death. The treatment is delivered to patients using a portable, wearable medical device. NovoCure's primary mission is to extend survival in some of the most aggressive forms of cancer. Its technology is commercially available for certain brain cancers and is under late-stage clinical investigation for various other solid tumors, including pancreatic, non-small cell lung, and ovarian cancers.